CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance - Wikidata - wikimedia - TriplyDB

CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance

CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance

http://www.wikidata.org/entity/Q34055274

about

Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment Hedgehog Signaling in the Maintenance of Cancer Stem Cells Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy Molecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cells From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer Identifying and targeting cancer stem cells in the treatment of gastric cancer.A unified model of the hierarchical and stochastic theories of gastric cancer.GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer Ramucirumab: successfully targeting angiogenesis in gastric cancer.Gastric cancer stem cells: evidence, potential markers, and clinical implications.Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.Identifying therapeutic targets in gastric cancer: the current status and future direction Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression.Smoothened is a poor prognosis factor and a potential therapeutic target in glioma.Hedgehog pathway aberrations and gastric cancer; evaluation of prognostic impact and exploration of therapeutic potentials.MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells.Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1+ colorectal cancer stem cells.Hedgehog signaling in the stomach.Hedgehog Signaling Links Chronic Inflammation to Gastric Cancer Precursor Lesions.Anti-Cancer Phytometabolites Targeting Cancer Stem Cells Hedgehog signaling pathway as a potential target in the treatment of advanced gastric cancer.Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer.SHh-Gli1 signaling pathway promotes cell survival by mediating baculoviral IAP repeat-containing 3 (BIRC3) gene in pancreatic cancer cells.CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.Intratracheal Administration of Hyaluronan-Cisplatin Conjugate Nanoparticles Significantly Attenuates Lung Cancer Growth in Mice.CD24 Expression Is Increased in 5-Fluorouracil-Treated Esophageal Adenocarcinoma Cells.A novel multikinase inhibitor R8 exhibits potent inhibition on cancer cells through both apoptosis and autophagic cell death.Whether CD44 is an applicable marker for glioma stem cells.Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.SLC34A2 regulates miR-25-Gsk3β signaling pathway to affect tumor progression in gastric cancer stem cell-like cells.Upregulated miR-132 in Lgr5+ gastric cancer stem cell-like cells contributes to cisplatin-resistance via SIRT1/CREB/ABCG2 signaling pathway.Alterations in cancer stem-cell marker CD44 expression predict oncologic outcome in soft-tissue sarcomas.A literature mining-based approach for identification of cellular pathways associated with chemoresistance in cancer.Gastric cancer and Hedgehog signaling pathway: emerging new paradigms.Are ovarian cancer stem cells the target for innovative immunotherapy?Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma.

P2860

Q26744536-7561EC27-E1D3-46BC-AE0C-38CE020C1E2C Q26764740-A27AFA3C-60EA-4600-A51D-2ABFCA44D7CC Q26798191-D3CA89DB-C054-45F6-9A17-78974593E7BE Q26798420-E3960F5A-7337-4A6A-9BB6-7CDF736F3A26 Q26865136-4E77D8CA-0F2A-4C7E-945A-1984532FCD71 Q28081405-E485EF7C-66AE-40F5-A529-AE431CA65AA5 Q28082921-73B2733A-EEFC-4FE0-BA31-BA48BF0F75D4 Q30238811-A225BD2D-18EB-4E60-80DA-3B1C3670C24A Q33577624-9094A7DE-EFCE-4192-8F7E-C02506E51CA3 Q33689071-20F10B5A-4025-4260-949B-B8E62B645823 Q34616558-23DA007A-1143-402F-8754-BB9BB250AC3D Q35795934-D7AA70F3-B161-4B46-9BEB-FA59FFFA84AD Q35832351-B30F87DB-FF29-445F-9710-CF81A2B5328D Q36398732-2A93D8B6-EE18-4669-B154-FF79EB0E9F26 Q36665156-5BD6FD48-9283-4B73-8463-3B1B141739CF Q36771655-C0830D80-D4E2-4591-B8B2-365FE37F8B29 Q37376531-AE23987D-33D3-4726-BEB8-64B5BF73151C Q37640309-0B8C948C-1AE6-47AB-B299-CF9C5F75CC3D Q38354853-319880D5-7161-48DF-AD12-7828A273DCD6 Q38695440-EC4887E6-0529-4220-AA17-72ACC3DEB1E7 Q38699403-794989D2-52DD-4188-B0DC-8AA4E3869C58 Q38983010-16C05E41-E57E-4E80-B0E9-75937CEA8933 Q39169684-4BBE832A-1513-4A89-978A-DFD6A31C71E3 Q39214227-7AC2FEA5-22D3-4B09-AE95-902D15AD3E71 Q39377902-6E9579AF-EE27-47C2-8A8D-4FDC4D8450ED Q39749680-8D2E6CB5-2ED8-4DC4-8249-4F00EC181AF8 Q40056036-AA857E06-C1FC-4B92-A3AA-719F4126C5D8 Q41294963-E57195F2-B19D-4A7A-A0F3-2D25408DC7B0 Q41656021-5915AFEA-40E1-4A67-B0B4-F2BC6E6C15D4 Q42240172-4EEDCE40-BCB8-43E3-B2A4-B8881F3AE8B7 Q44869860-D52E9A1C-45B9-438A-81B2-D6D81487CFB9 Q47095291-CC244B74-2399-4AE3-A703-8897D0CCBBFC Q47922873-D746DE17-77AA-47AA-BFF6-E31349FB2EB6 Q48232383-93DE63B5-F050-4598-941C-4E6571937DAC Q48312418-6978C94E-F8C3-41D9-8C4F-E382145C7AB9 Q50056834-A4FC2F9D-D816-420D-8723-E8CF446E9704 Q50875340-44780FA1-FF0D-427F-93F6-900E29971EFF Q54945791-B4506146-7389-45E5-BDF4-1998EB500DC5 Q55164226-BEE27A23-3923-45AA-B355-44570B35665D Q55302141-93D655F9-8AF9-4F8A-80BC-CA0E5DDB5BA2

P2860

CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance

http://www.wikidata.org/entity/Q34055274

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

CD44 expression denotes a subp ...... omotes chemotherapy resistance

@ast

CD44 expression denotes a subp ...... omotes chemotherapy resistance

@en

CD44 expression denotes a subp ...... omotes chemotherapy resistance

@nl

type

label

CD44 expression denotes a subp ...... omotes chemotherapy resistance

@ast

CD44 expression denotes a subp ...... omotes chemotherapy resistance

@en

CD44 expression denotes a subp ...... omotes chemotherapy resistance

@nl

prefLabel

CD44 expression denotes a subp ...... omotes chemotherapy resistance

@ast

CD44 expression denotes a subp ...... omotes chemotherapy resistance

@en

CD44 expression denotes a subp ...... omotes chemotherapy resistance

@nl

P1433

Q34055274-DDFF23BD-2610-4C07-90AA-DB5F60981D64

P1476

Q34055274-545BC034-F8F8-442A-A0D1-359BDEDBFB53

P2093

Q34055274-2581B885-01C3-417B-922A-12774CC4498E

Q34055274-4242B669-6D51-4802-ADA1-0DE15DAC8DDD

Q34055274-45F5A646-78AC-48AC-855D-7292164E014E

Q34055274-5BAED08B-BD85-45AA-A067-68BB84842CD8

Q34055274-8CCBEF6D-0DF1-4DC7-A19C-45732A5A0670

Q34055274-CE73FF06-5977-4F14-8ACB-59857621DA64

Q34055274-E517080F-73A8-4CDC-8A07-7EB105C1E236

P2860

Q34055274-052042B9-C76D-4FF9-B138-E8436B59D443

Q34055274-0955DFD0-6205-4197-84A8-33342AE3B003

Q34055274-1B54EF1C-6A6E-40FE-BABA-ECB499AE1806

Q34055274-1BF16A2A-B2C2-4366-8F2C-852218427D0F

Q34055274-1FE28283-1913-4B39-A94F-CEAAE30C2B85

Q34055274-2D12B482-DB06-4D27-A24D-7F9505461CD0

Q34055274-2DC3FE58-B696-4209-A12F-05E12B5DB654

Q34055274-32AEB2D6-F1D0-4A5A-9155-D9EA827FB94B

Q34055274-3A746929-301C-44DB-922F-074BB2007D83

Q34055274-3CE1E6A6-6F49-4225-B908-6A5D5106AD25

P304

Q34055274-ACE8CD48-F6B0-44F1-B83E-112FF2DA10DC

P31

Q34055274-DD11CD7D-D265-4D2F-A586-9BA38BE71A9A

P356

Q34055274-AAFAEB0C-BB9B-4A09-9CC2-8707ABA1E776

P407

Q34055274-B4743721-B623-45BE-9ED5-7361CE40547F

P433

Q34055274-5CA98AE0-B89E-40F2-974A-BC0B9D93359C

P478

Q34055274-B0B168CB-3BEA-42F9-B3C7-AE41769F8BA1

P50

Q34055274-18B5585D-9F18-4A64-9936-B85145D7BB2C

Q34055274-D5F19C0E-4A8B-4917-B02B-5A8E0A535D7A

P577

Q34055274-856C56C4-33FF-4C2E-98E4-E04DF3B861AC

P698

Q34055274-0D4508D5-FF3B-4FAC-BE3C-7FAAD410B478

P921

Q34055274-26612BB5-C3C4-4E18-894C-0BABD77628FD

P932

Q34055274-F3A8DF32-43D0-440D-97BE-2F81025F6A79

P356

1078-0432.CCR-14-0011

P1433

Clinical Cancer Research

P1476

CD44 expression denotes a subp ...... omotes chemotherapy resistance

@en

P2093

Benjamin Schmidt

http://www.w3.org/2001/XMLSchema#string

Changhwan Yoon

http://www.w3.org/2001/XMLSchema#string

Do Joong Park

http://www.w3.org/2001/XMLSchema#string

Hae-June Lee

http://www.w3.org/2001/XMLSchema#string

Nicholas J Thomas

http://www.w3.org/2001/XMLSchema#string

Sam S Yoon

http://www.w3.org/2001/XMLSchema#string

Yelena Y Janjigian

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Efficient tumour formation by single human melanoma cells

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

The Hedgehog response network: sensors, switches, and routers

A restricted cell population propagates glioblastoma growth after chemotherapy

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

P304

3974-3988

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-14-0011

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24947926

http://www.w3.org/2001/XMLSchema#string

P921

P932

4135312

http://www.w3.org/2001/XMLSchema#string